Status:
COMPLETED
Effect of Icodextrin Solution on Preservation of Residual Renal Function in Patients on Peritoneal Dialysis
Lead Sponsor:
Yonsei University
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Peritoneal dialysis (PD) is an established dialysis modality in patients with end stage renal disease (ESRD). However, there is growing awareness of the deleterious effect of high glucose content in P...
Eligibility Criteria
Inclusion
- Patients who were maintained on PD for over 3 months.
- Patients with residual renal function \> 750 ml/day.
- Patients who give informed consent.
Exclusion
- patients less than 20 years of age,
- uncontrolled volume status requiring the repeated use of 4.25% glucose PD solutions in addition to 2.5% glucose PD solution or icodextrin,
- volume depletion or hypotension (systolic blood pressure \< 90 mmHg) caused by 2.5% glucose PD solution or icodextrin solution,
- allergic to starch,
- life expectancy less than 12 months,
- prior history of kidney transplantation or hemodialysis,
- patients on automated PD.
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01170858
Start Date
August 1 2010
End Date
August 1 2014
Last Update
January 20 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance Hospital
Seoul, South Korea, 120-752